← Oncology Approval Tracker

FDA DECISION ·

Nilotinib capsules (first generic)

nilotinib hydrochloride · Apotex

First generic approvalFirst genericChronic myeloid leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic of the referenced nilotinib capsules. Labeled settings include newly diagnosed chronic-phase Philadelphia chromosome-positive CML in adults and children aged 1 year and older, and specified adult and pediatric chronic- or accelerated-phase disease after prior treatment resistance or intolerance.

LAMPGEN ANALYSIS

Why it matters

The capsule approval is distinct from a later nilotinib tablet formulation with different administration instructions.

What research teams should watch

Confirm capsule-specific fasting and QT precautions and distinguish pediatric prior-TKI criteria from adult prior-imatinib criteria.

PRIMARY RECORDS

Sources